These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18300346)

  • 1. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
    Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
    Agarwal KK; Shah D; Shah N; Mayank M
    Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
    Sun L; Wu H; Pan WM; Guan YS
    World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of
    Wu B; Zhang Y; Tan H; Shi H
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Malignant Portal Vein Thrombus in Colon Carcinoma: A Rare Finding on
    Jain TK; Yadav A; Malhotra H; Khunteta N; Singh G
    J Nucl Med Technol; 2021 Jun; 49(2):190-192. PubMed ID: 33219156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.
    Poddar N; Avezbakiyev B; He Z; Jiang M; Gohari A; Wang JC
    J Gastrointest Cancer; 2012 Sep; 43(3):486-9. PubMed ID: 21190093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
    Surasi DS; O'Malley JP; Bhambhvani P
    J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68 Ga-FAPI PET/MRI and 18 F-FDG PET/CT in a Case With Extensive Portal Vein Tumor Thrombus.
    Yao X; Liu W; Ou X
    Clin Nucl Med; 2023 Apr; 48(4):373-375. PubMed ID: 36716458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
    Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
    Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
    Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
    Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.